DSCAM and hereditary clear cell renal cell carcinoma: These findings suggest that NTN1, DSCAM, and NEO1 are regulated by HDACs in renal cell carcinoma, thus providing new concepts for the use of HDACis in the treatment of renal cell carcinoma.